- Correction
- Open access
- Published:
Correction: Rethinking the pros and cons of randomized controlled trials and observational studies in the era of big data and advanced methods: a panel discussion
BMC Proceedings volume 18, Article number: 16 (2024)
Correction: BMC Proc 18 (Suppl 2), 1 (2024)
https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12919-023-00285-8
Following publication of the original article [1], the authors requested to update the funding section. The original and updated funding statements are given below:
Original: This work was funded by a Canadian Institutes of Health Research grant (#178264).
Updated: This work was funded by the Canadian Institutes of Health Research grant (#178264). The authors would like to thank the Quebec Population Health Research Network (QPHRN) for its contribution to the financing of this open-access publication. Ce travail a été financé par une subvention des Instituts de recherche en santé du Canada (#178264). Les auteurs remercient l’axe Politiques publiques et santé des population du Réseau de recherche en santé des populations du Québec (RRSPQ) pour sa contribution au financement de cet article.
The original article [1] has been updated.
Reference
Fernainy P, Cohen AA, Murray E, et al. Rethinking the pros and cons of randomized controlled trials and observational studies in the era of big data and advanced methods: a panel discussion. BMC Proc. 2024;18(Suppl 2):1. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12919-023-00285-8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Fernainy, P., Cohen, A.A., Murray, E. et al. Correction: Rethinking the pros and cons of randomized controlled trials and observational studies in the era of big data and advanced methods: a panel discussion. BMC Proc 18, 16 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12919-024-00299-w
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12919-024-00299-w